Abstract
C-reactive protein (CRP) has been regarded as a most valuable marker of inflammation that had been shown in prediction of multiple prospective blood vascular studies such as an incident myocardial infarcion, stroke, peripheral arterial disease, and sudden cardiac death. A CRP detection system on a solid surface was developed using dual-antibody binding, which first antibody was immobilized by specific binding with Protein A via a fusion form with streptavidin. Second antibody bound with CRP was used for an electrochemical analysis on the gold chip surface. The fusion protein and antibodies could be successfully immobiized on the gold surface by strong biotin-streptavidin nteraction as examined by surface plasmon resonance analysis. The result showed that the limit of detection has reached at 2 pg/mL. Precision is adequate, and the wide-range response was shown with the concentraion of CRP between 0.01 pg/mL to 1 mg/mL. Signal difference for the same sample among different estabished chips is very low. Besides, the stable electrical signal was apparently maintained (~88% of initial response) for 35 days after storage at 4°C. This study provided a possibility for the development of portable chips or CRP detection, especially in the point-of-care use.
Similar content being viewed by others
References
Kindmark, C.O. The Concentration of C-Reactive Protein in Sera from Healthy Individuals. Scand. J. Clin. Lab. Invest. 29, 407–11 (1972).
Kushner, I. & Rzewnicki, D.L. The Acute Phase Response: General Aspects. Bailliere’s Clin. Rheumatol. 8, 513–30 (1994).
Macy, E.M., Hayes, T.E. & Tracy, R.P. Variability in the Measurement of C-Reactive Protein in Healthy Subjects: Implications for Reference Intervals and Epidemiological Applications. Clin. Chem. 43, 52–8 (1997).
Yudkin, J.S., Stehouwer, C.D.A., Emeis, J.J. & Coppack, S.W. C-Reactive Protein in Healthy Subjects: Associations with Obesity, Insulin Resistance, and Endothelial Dysfunction: A Potential Role for Cytokines Originating from Adipose Tissue? Arterioscler. Throm. Vas. Biol. 19, 972–78 (1999).
Retterstol, L., Eikvar, L. & Berg, K. A Twin Study of C-Reactive Protein Compared to Other Risk Factors for Coronary Heart Disease. Atherosclerosis 169, 279–82 (2003).
Hedlund, P. The Appearance of Acute Phase Protein in Various Diseases. Acta Med. Scand. 128, 579–01 (1947).
Hedlund, P. Clinical and Experimental Studies on CReactive Protein (Acute Phase Protein). Acta Med. Scand. 128, 1–1 (1961).
Dowling, P. & Cook, S. In Immune Events in Demyelinating Disease; Wolfgang, F., Ellison, G.W., Stevens, J.G. & Andrew, J.M. Ed., Academic Press Inc., New York, NY, USA, pp. 269–77 (1972).
Ridker, P.M. Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention. J. Am. Heart Assoc. Circulation 107, 363–69 (2003).
Bassuk, S.S., Rifai, N. & Ridker, P.M. High-sensitivity C-Reactive Protein: Clinical Importance. Curr. Probl. Cardiol. 29, 439–93 (2004).
Ridker, P.M. & Cook, N.R. Clinical Usefulness of Very High and Very Low Levels of C-Reactive Protein Across a Full Range of Framingham Risk Scores. Circulation 109, 1955–959 (2004).
Chou, C. et al. Fiber Optic Biosensor for the Detection of C-Reactive Protein and the Study of Protein Binding Kinetics. J. Biomed. Opt. 12, 024025 (2007).
Hosokawa, K., Omata, M., Sato, K. & Maeda, M. Power-free Sequential Injection for Microchip Immunoassay toward Point-of-care Testing. Lab Chip 6, 236–41 (2006).
Hu, W.P. et al. Immunodetection of Pentamer and Modified C-Reactive Protein Using Surface Plasmon Resonance Biosensing. Biosens. Bioelectron. 21, 1631–637 (2006).
Ibraimi, F., Kriz, D., Lu, M., Hansson, L.O. & Kriz, K. Rapid One-step Whole Blood C-Reactive Protein Magnetic Permeability Immunoassay with Monoclonal Antibody Conjugated Nanoparticles as Superparamagnetic Labels and Enhanced Sedimentation. Anal. Bioanal. Chem. 384, 651–57 (2006).
Inger, V.L. & Willem, M.A. Site-directed Immobilisation of Antibody Fragments for Detection of C-Reactive Protein. Biosens. Bioelectron. 21, 1141–148 (2006).
Li, S.L. et al. Disposable Polydimethylsiloxane/Silicon Hybrid Chips for Protein Detection. Biosens. Bioelectron. 21, 574–80 (2005).
Kriz, K., Ibraimi, F., Lu, M., Hansson, L.O. & Kriz, D. Detection of C-Reactive Protein Utilizing Magnetic Permeability Detection Based Immunoassays. Anal. Chem. 77, 5920–924 (2005).
Lee, E.-H. et al. SPR Biosensor Based on Immobilized E. coli cells with Autodisplayed Z-domains. BioChip J. 6, 221–28 (2012).
Meyer, M.H.F. et al. CRP Determination Based on a Novel Magnetic Biosensor. Biosens. Bioelectron. 22, 973–79 (2007).
Padigi, S.K. et al. Micro-Photonic Cylindrical Waveguide Based Protein Biosensor. Nanotechnology 17, 4384–390 (2006).
Raj, V., Hari, P.R. & Sreenivasan, K. Use of Chemically Modified Thermoresponsive Copolymers for the Detection of C-Reactive Protein. Anal. Chim. Acta 592, 45–0 (2007).
Tsai, H.Y., Hsu, C.F., Chiu, I.W. & Fuh, C.B. Detection of C-Reactive Protein Based on Immunoassay Using Antibody-Conjugated Magnetic Nanoparticles. Anal. Chem. 79, 8416–419 (2007).
Wee, K.W. et al. Novel Electrical Detection of LabelFree Disease Marker Proteins Using Piezoresistive Self-sensing Micro-cantilevers. Biosens. Bioelectron. 20, 1932–938 (2005).
Rossier, J.S., Roberts, M.A., Ferrigno, R. & Girault, H.H. Electrochemical Detection in Polymer Microchannels. Anal. Chem. 71, 4294–299 (1999).
Rossier, J.S., Ferrigno, R. & Girault, H.H. Electrophoresis with Electrochemical Detection in a Polymer Microdevice. J. Electroanal. Chem. 492, 15–2 (2000).
Wang, J., Tian, B. & Sahlin, E. Integrated Electrophoresis Chips/Amperometric Detection with Sputtered Gold Working Electrodes. Anal. Chem. 71, 3902–905 (1999).
Wang, J., Chatrathi, M.P. & Tian, B. Capillary Electrophoresis Microchips with Thick-film Amperometric Detectors: Separation and Detection of Phenolic Compounds. Anal. Chim. Acta 416, 9–4 (2000).
Hafaiedh, I. et al. Supported Protein G on Gold Electrode: Characterization and Immunosensor Application. Talanta 116, 84–0 (2013).
Roberts, W.L. et al. Evaluation of Nine Automated High-sensitivity C-Reactive Protein Methods: Implications for Clinical and Epidemiological Applications. Part 2. Clin. Chem. 47, 418–25 (2001).
Franco, E.J., Hofstetter, H. & Hofstetter, O.A. Comparative Evaluation of Random and Site-specific Immobilization Techniques for the Preparation of Antibody-based Chiral Stationary Phases. J. Sep. Sci. 29, 1458–469 (2006).
Oh, B.K., Kim, Y.K., Park, K.W., Lee, W.H. & Choi, J.W. Surface Plasmon Resonance Immunosensor for the Detection of Salmonella Typhimurium. Biosens. Bioelectron. 19, 1497–504 (2004).
Schmid, A.H., Stanca, S.E., Thakur, M.S., Thampi, R.K. & Suri, C.R. Site-directed Antibody Immobilization on Gold Substrate for Surface Plasmon Resonance Sensors. Sensor. Actuat. B-Chem. 113, 297–03 (2006).
Kokkinos, C., Economou, A., Petrou, P.S. & Kakabakos, S.E. Microfabricated Tin-Film Electrodes for Protein and DNA Sensing Based on Stripping Voltammetric Detection of Cd (II) Released from Quantum Dots Labels. Anal. Chem. 85, 10686–0691 (2013).
Chaisuwan, N., Xu, H., Wu, G. & Liu, J. A Highly Sensitive Differential Pulse Anodic Stripping Voltammetry for Determination of 17β-estradiol (E2) Using CdSe Quantum Dots Based on Indirect Competitive Immunoassay. Biosens. Bioelectron. 46, 150–54 (2013).
Bollag, D.M., Rozycki, M.D. & Edelstein, S.J. In Protein Methods; Protein Concentration Determination; Edelstein, S.J., Ed., Wiley-Liss, New York, NY, USA, pp. 62–7 (1996).
Author information
Authors and Affiliations
Corresponding author
Additional information
These authors contributed equally to this work
Rights and permissions
About this article
Cite this article
Kim, G.W., Zheng, S., Kim, M.S. et al. Development of specific immobilization method on gold surface and its application for determining cardiac risk. BioChip J 8, 295–302 (2014). https://doi.org/10.1007/s13206-014-8408-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13206-014-8408-4